Saqlain Farees, Shalhout Sophia Z, Emerick Kevin S, Neilan Tomas G, Sharova Tatyana, Miller David Michael
Harvard Medical School, Boston, MA, USA.
Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.
Case Rep Dermatol Med. 2020 Sep 30;2020:8890845. doi: 10.1155/2020/8890845. eCollection 2020.
Merkel cell carcinoma is a rare cutaneous neuroendocrine carcinoma with a high rate of regional and distant metastasis and mortality. Here, we report a novel case of Merkel cell carcinoma which presented as a primary lesion to the left cheek with regional lymph node involvement and was treated with pembrolizumab and radiation. Widely metastatic disease eventually revealed on autopsy clinically mimicked immune-related organ insult leading to management with immunosuppressants. The patient also had a biopsy-confirmed immune-related cutaneous adverse event during admission. The case highlights a rare circumstance in which disease progression masqueraded as multiple immune-related end-organ adverse events. Contribution of on-target anti-PD-1 toxicity remains a possibility.
默克尔细胞癌是一种罕见的皮肤神经内分泌癌,具有较高的区域和远处转移率及死亡率。在此,我们报告一例新的默克尔细胞癌病例,该病例以左侧脸颊原发性病变伴区域淋巴结受累为表现,接受了帕博利珠单抗和放疗治疗。尸检最终发现广泛转移的疾病在临床上模拟了免疫相关器官损伤,导致使用免疫抑制剂进行治疗。患者在住院期间还发生了经活检证实的免疫相关皮肤不良事件。该病例突出了一种罕见情况,即疾病进展伪装成多种免疫相关终末器官不良事件。靶向抗程序性死亡蛋白1(PD-1)毒性的作用仍有可能。